Online citations, reference lists, and bibliographies.
← Back to Search

An Investigation Of Adequate Volume For The Diagnosis Of Malignancy In Pleural Fluids

S. Thomas, L. Davidson, M. McKean
Published 2011 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
S. C. Thomas, L. R. R. Davidson and M. E. McKean
This paper references

This paper is referenced by
Positive pleural cytology is an indicator for visceral pleural invasion in metastatic pleural effusions
M. Froudarakis (2018)
Number of mesothelial cells as a measure of adequacy criteria for pleural effusions: A multi‐institutional study
Erika F. Rodriguez (2020)
Diagnostic molecular biomarkers for malignant pleural effusions.
K. Sriram (2011)
ERS/EACTS statement on the management of malignant pleural effusions
A. Bibby (2018)
A minimum fluid volume of 75 mL is needed to ensure adequacy in a pleural effusion: A retrospective analysis of 2540 cases
Lisa M. Rooper (2014)
Management of malignant pleural effusion
R. Boshuizen (2017)
[Pre-analytical quality in fluid samples cytopathology: Results of a survey from the French Society of Clinical Cytology].
M. Courtade-Saïdi (2015)
Year in review 2011: Respiratory infections, tuberculosis, pleural diseases, bronchoscopic intervention and imaging
J. M. Porcel (2012)
Qualité pré-analytique en cytopathologie des liquides biologiques : résultats d’une enquête de la Société française de cytologie clinique
Monique Courtade-Saïdi (2015)
Diagnostic Yield of Pleural Fluid Cytology in Malignant Pleural Effusion
M. Asim (2016)
Collection and Handling of Thoracic Small Biopsy and Cytology Specimens for Ancillary Studies Guideline from the College of American Pathologists (CAP): implications for the cytology community.
P. VanderLaan (2020)
Collection and Handling of Thoracic Small Biopsy and Cytology Specimens for Ancillary Studies: Guideline From the College of American Pathologists in Collaboration With the American College of Chest Physicians, Association for Molecular Pathology, American Society of Cytopathology, American Thoracic
S. Roy-Chowdhuri (2020)
Suspicious for Malignancy Diagnoses on Pleural Effusion Cytology.
E. Rodriguez (2020)
A 2‐year retrospective study on pleural effusions: A cancer centre experience
E. Valerio (2019)
The International System for Serous Fluid Cytopathology
A. Chandra (2020)
Root cause analysis of indeterminate diagnoses in serous fluids cytopathology.
Hamza N. Gokozan (2020)
A Minimum Volume of More Than 60 mL Is Necessary for Adequate Cytologic Diagnosis of Malignant Pericardial Effusions.
Lisa M. Rooper (2016)
Assessment of a panel of tumor markers for the differential diagnosis of benign and malignant effusions by well-based reverse phase protein array
T. Braunschweig (2015)
Current controversies in the management of malignant pleural effusions.
M. Azzopardi (2014)
A specimen volume of ≥80 mL improves cytologic sensitivity for malignant ascites: a retrospective analysis of 2665 cases.
Lisa M. Rooper (2016)
The international system for reporting serous fluid cytopathology-diagnostic categories and clinical management.
D. Pinto (2020)
Analysis of Pleural Effusion Cases Diagnosed with Uniportal Video Assisted Thoracoscopic Surgery
M. A. Haberal (2019)
Diagnosis of Pleural Effusions
J. M. Porcel (2013)
ERS/EACTS statement on the management of malignant pleural effusions
A. Bibby (2019)
Non-diagnostic (ND) and Adequacy
M. Saieg (2020)
Semantic Scholar Logo Some data provided by SemanticScholar